SCHEMBL29960417

SCHEMBL29960417

c1ccc(CN2CCCC3(CCOc4ccccc43)C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.47
SIGMAR1 Q99720 8/20 0.46
CYP3A4 P08684 3/20 0.46
TSHR P16473 3/20 0.46
TP53 P04637 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
DRD2 P14416 1/20 0.46
NFKB1 P19838 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
MAPK1 P28482 1/20 0.46
HTR2B P41595 1/20 0.46
MTOR P42345 1/20 0.46
MEN1 O00255 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1587962 0.84 SIGMAR1 (0.59) CYP2D6SIGMAR1CYP3A4TSHRTP53
SCHEMBL9049446 0.82 SIGMAR1 (0.49) CYP2D6SIGMAR1CYP3A4TSHRDRD2
SCHEMBL3217199 0.80 SIGMAR1 (0.51) CYP2D6SIGMAR1CYP3A4TSHRTP53
SCHEMBL1587952 0.74 SIGMAR1 (0.57) CYP2D6SIGMAR1CYP3A4TSHRTP53
SCHEMBL6628811 0.73 SIGMAR1 (0.48) CYP2D6SIGMAR1CYP3A4TSHRTP53
SCHEMBL28605146 0.72 ITGB2 (0.43) ALDH1A1
SCHEMBL14385756 0.72 KCNH2 (0.52) SIGMAR1
SCHEMBL21167264 0.72 S1PR5 (0.61)
SCHEMBL30353245 0.70 ITGB2 (0.44) KMT2A
SCHEMBL6634600 0.70 S1PR5 (0.44) SIGMAR1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed